[논문]E. coli -Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine

Nguyen, Quyen Thi; Kim, Eunjin; Yang, Jihyun; Lee, Chankyu; Ha, Da Hui; Lee, Choon Geun; Lee, Ye Ram; Poo, Haryoung

doi:10.3390/vaccines8020306

[해외논문] E. coli -Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine 원문보기

Vaccines, v.8 no.2, 2020년, pp.306 -

Nguyen, Quyen Thi (Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea) , Kim, Eunjin (quyenbio@kribb.re.kr (Q.T.N.)) , Yang, Jihyun (ejkim@kribb.re.kr (E.K.)) , Lee, Chankyu (jhyang@kribb.re.kr (J.Y.)) , Ha, Da Hui (Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea) , Lee, Choon Geun (quyenbio@kribb.re.kr (Q.T.N.)) , Lee, Ye Ram (ejkim@kribb.re.kr (E.K.)) , Poo, Haryoung (jhyang@kribb.re.kr (J.Y.))

Abstract ▼ AI-Helper

Emerging influenza viruses pose an extreme global risk to human health, resulting in an urgent need for effective vaccination against influenza infection. Adjuvants are vital components that can improve vaccine efficacy, yet only a few adjuvants have been licensed in human vaccines. Here, we investigate the adjuvant effects of Escherichia coli-produced monophosphoryl lipid A (MPL), named EcML, in enhancing the immunogenicity and efficacy of an influenza vaccine. Similar to MPL, EcML activated dendritic cells and enhanced the antigen processing of cells in vitro. Using ovalbumin (OVA) as a model antigen, EcML increased OVA-specific antibody production, cytotoxic T lymphocyte activity. The safety of EcML was demonstrated as being similar to that of MPL by showing not significant in vitro cell cytotoxicity but transient systemic inflammatory responses within 24 h in OVA immunized mice. Importantly, mice vaccinated with pandemic H1N1 (pH1N1) vaccine antigen, combined with EcML, were fully protected from pH1N1 virus infection by enhanced influenza-specific antibody titers, hemagglutination inhibition titers, and IFN-γ- secreting cells. Taken together, our results strongly suggest that EcML might be a promising vaccine adjuvant for preventing influenza virus infection.

Keyword

참고문헌 (44)

1. Bar-On Y. Glasner A. Meningher T. Achdout H. Gur C. Lankry D. Vitenshtein A. Meyers A.F. Mandelboim M. Mandelboim O. Neuraminidase-mediated, nkp46-dependent immune-evasion mechanism of influenza viruses Cell Rep. 2013 3 1044 1050 10.1016/j.celrep.2013.03.034 23602571

상세보기
2. Glezen W.P. Emerging infections: Pandemic influenza Epidemiol. Rev. 1996 18 64 76 10.1093/oxfordjournals.epirev.a017917 8877331

상세보기
3. Dawood F.S. Iuliano A.D. Reed C. Meltzer M.I. Shay D.K. Cheng P.Y. Bandaranayake D. Breiman R.F. Brooks W.A. Buchy P. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza a h1n1 virus circulation: A modelling study Lancet Infect. Dis. 2012 12 687 695 10.1016/S1473-3099(12)70121-4 22738893

상세보기
4. Tregoning J.S. Russell R.F. Kinnear E. Adjuvanted influenza vaccines Hum. Vaccines Immunother. 2018 14 550 564 10.1080/21645515.2017.1415684

상세보기
5. Marrack P. McKee A.S. Munks M.W. Towards an understanding of the adjuvant action of aluminium Nat. Rev. Immunol. 2009 9 287 293 10.1038/nri2510 19247370

상세보기
6. Sivakumar S.M. Safhi M.M. Kannadasan M. Sukumaran N. Vaccine adjuvants-current status and prospects on controlled release adjuvancity Saudi. Pharm. J. 2011 19 197 206 10.1016/j.jsps.2011.06.003 23960760

상세보기
7. Miller E. Andrews N. Stellitano L. Stowe J. Winstone A.M. Shneerson J. Verity C. Risk of narcolepsy in children and young people receiving as03 adjuvanted pandemic a/h1n1 2009 influenza vaccine: Retrospective analysis BMJ 2013 346 f794 10.1136/bmj.f794 23444425

상세보기
8. Nohynek H. Jokinen J. Partinen M. Vaarala O. Kirjavainen T. Sundman J. Himanen S.L. Hublin C. Julkunen I. Olsen P. As03 adjuvanted ah1n1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in finland PLoS ONE 2012 7 e33536 10.1371/journal.pone.0033536 22470453

상세보기
9. Kumar H. Kawai T. Akira S. Toll-like receptors and innate immunity Biochem. Biophys. Res. Commun. 2009 388 621 625 10.1016/j.bbrc.2009.08.062 19686699

상세보기
10. Reed S.G. Hsu F.C. Carter D. Orr M.T. The science of vaccine adjuvants: Advances in tlr4 ligand adjuvants Curr. Opin. Immunol. 2016 41 85 90 10.1016/j.coi.2016.06.007 27392183

상세보기
11. Gregg K.A. Harberts E. Gardner F.M. Pelletier M.R. Cayatte C. Yu L. McCarthy M.P. Marshall J.D. Ernst R.K. Rationally designed tlr4 ligands for vaccine adjuvant discovery MBio 2017 8 e00492-17 10.1128/mBio.00492-17 28487429

상세보기
12. Yang J. Shim S.M. Nguyen T.Q. Kim E.H. Kim K. Lim Y.T. Sung M.H. Webby R. Poo H. Poly-gamma-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of h1n1 pandemic influenza vaccine Sci. Rep. 2017 7 44839 10.1038/srep44839 28322289

상세보기
13. Nguyen Q.T. Kwak C. Lee W.S. Kim J. Jeong J. Sung M.H. Yang J. Poo H. Poly-gamma-glutamic acid complexed with alum induces cross-protective immunity of pandemic h1n1 vaccine Front. Immunol. 2019 10 1604 10.3389/fimmu.2019.01604 31354739

상세보기
14. Steinhagen F. Kinjo T. Bode C. Klinman D.M. Tlr-based immune adjuvants Vaccine 2011 29 3341 3355 10.1016/j.vaccine.2010.08.002 20713100

상세보기
15. Paavonen J. Jenkins D. Bosch F.X. Naud P. Salmeron J. Wheeler C.M. Chow S.N. Apter D.L. Kitchener H.C. Castellsague X. Efficacy of a prophylactic adjuvanted bivalent l1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase iii double-blind, randomised controlled trial Lancet 2007 369 2161 2170 10.1016/S0140-6736(07)60946-5 17602732

상세보기
16. Kundi M. New hepatitis b vaccine formulated with an improved adjuvant system Expert Rev. Vaccines 2007 6 133 140 10.1586/14760584.6.2.133 17408363

상세보기
17. Mata-Haro V. Cekic C. Martin M. Chilton P.M. Casella C.R. Mitchell T.C. The vaccine adjuvant monophosphoryl lipid a as a trif-biased agonist of tlr4 Science 2007 316 1628 1632 10.1126/science.1138963 17569868

상세보기
18. Casella C.R. Mitchell T.C. Putting endotoxin to work for us: Monophosphoryl lipid a as a safe and effective vaccine adjuvant Cell Mol. Life Sci. 2008 65 3231 3240 10.1007/s00018-008-8228-6 18668203

상세보기
19. Reed S.G. Carter D. Casper C. Duthie M.S. Fox C.B. Correlates of gla family adjuvants’ activities Semin. Immunol. 2018 39 22 29 10.1016/j.smim.2018.10.004 30366662

상세보기
20. Ji Y. An J. Hwang D. Ha D.H. Lim S.M. Lee C. Zhao J. Song H.K. Yang E.G. Zhou P. Metabolic engineering of escherichia coli to produce a monophosphoryl lipid a adjuvant Metab. Eng. 2020 57 193 202 10.1016/j.ymben.2019.11.009 31786244

상세보기
21. Zuo B. Qi H. Lu Z. Chen L. Sun B. Yang R. Zhang Y. Liu Z. Gao X. You A. Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice Nat. Commun. 2020 11 1790 10.1038/s41467-020-15569-2 32286296

상세보기
22. Matheu M.P. Sen D. Cahalan M.D. Parker I. Generation of bone marrow derived murine dendritic cells for use in 2-photon imaging J. Vis. Exp. 2008 17 e773 10.3791/773 19066518

상세보기
23. Lim Y.T. Shim S.M. Noh Y.W. Lee K.S. Choi D.Y. Uyama H. Bae H.H. Kim J.H. Hong K.S. Sung M.H. Bioderived polyelectrolyte nanogels for robust antigen loading and vaccine adjuvant effects Small 2011 7 3281 3286 10.1002/smll.201101836 22009658

상세보기
24. Merad M. Sathe P. Helft J. Miller J. Mortha A. The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting Annu. Rev. Immunol. 2013 31 563 604 10.1146/annurev-immunol-020711-074950 23516985

상세보기
25. Iwasaki A. Medzhitov R. Toll-like receptor control of the adaptive immune responses Nat. Immunol. 2004 5 987 995 10.1038/ni1112 15454922

상세보기
26. Jeong Y. Kim G.B. Ji Y. Kwak G.J. Nam G.H. Hong Y. Kim S. An J. Kim S.H. Yang Y. Dendritic cell activation by an e. Coli-derived monophosphoryl lipid a enhances the efficacy of pd-1 blockade Cancer Lett. 2020 472 19 28 10.1016/j.canlet.2019.12.012 31857157

상세보기
27. Karin M. How nf-kappab is activated: The role of the ikappab kinase (ikk) complex Oncogene 1999 18 6867 6874 10.1038/sj.onc.1203219 10602462

상세보기
28. Ko E.J. Lee Y.T. Lee Y. Kim K.H. Kang S.M. Distinct effects of monophosphoryl lipid a, oligodeoxynucleotide cpg, and combination adjuvants on modulating innate and adaptive immune responses to influenza vaccination Immune Netw. 2017 17 326 342 10.4110/in.2017.17.5.326 29093654

상세보기
29. Steinman R.M. Linking innate to adaptive immunity through dendritic cells Novartis Found. Symp. 2006 279 101 219 101？109; discussion 109？113, 216？219 17278389

상세보기
30. Seubert A. Monaci E. Pizza M. O’Hagan D.T. Wack A. The adjuvants aluminum hydroxide and mf59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells J. Immunol. 2008 180 5402 5412 10.4049/jimmunol.180.8.5402 18390722

상세보기
31. Levitz S.M. Golenbock D.T. Beyond empiricism: Informing vaccine development through innate immunity research Cell 2012 148 1284 1292 10.1016/j.cell.2012.02.012 22424235

상세보기
32. Mosaheb M.M. Reiser M.L. Wetzler L.M. Toll-like receptor ligand-based vaccine adjuvants require intact myd88 signaling in antigen-presenting cells for germinal center formation and antibody production Front. Immunol. 2017 8 225 10.3389/fimmu.2017.00225 28316602

상세보기
33. Didierlaurent A.M. Laupeze B. Di Pasquale A. Hergli N. Collignon C. Garcon N. Adjuvant system as01: Helping to overcome the challenges of modern vaccines Expert Rev. Vaccines 2017 16 55 63 10.1080/14760584.2016.1213632 27448771

상세보기
34. Badovinac V.P. Messingham K.A. Jabbari A. Haring J.S. Harty J.T. Accelerated cd8+ t-cell memory and prime-boost response after dendritic-cell vaccination Nat. Med. 2005 11 748 756 10.1038/nm1257 15951824

상세보기
35. Black S. Della Cioppa G. Malfroot A. Nacci P. Nicolay U. Pellegrini M. Sokal E. Vertruyen A. Safety of mf59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis Vaccine 2010 28 7331 7336 10.1016/j.vaccine.2010.08.075 20813217

상세보기
36. Stassijns J. Bollaerts K. Baay M. Verstraeten T. A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children Vaccine 2016 34 714 722 10.1016/j.vaccine.2015.12.024 26740250

상세보기
37. Mei J. Riedel N. Grittner U. Endres M. Banneke S. Emmrich J.V. Body temperature measurement in mice during acute illness: Implantable temperature transponder versus surface infrared thermometry Sci. Rep. 2018 8 3526 10.1038/s41598-018-22020-6 29476115

상세보기
38. Olejnik J. Hume A.J. Muhlberger E. Toll-like receptor 4 in acute viral infection: Too much of a good thing PLoS Pathog. 2018 14 e1007390 10.1371/journal.ppat.1007390 30571771

상세보기
39. Simon W.L. Salk H.M. Ovsyannikova I.G. Kennedy R.B. Poland G.A. Cytokine production associated with smallpox vaccine responses Immunotherapy 2014 6 1097 1112 10.2217/imt.14.72 25428648

상세보기
40. Christian L.M. Porter K. Karlsson E. Schultz-Cherry S. Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination Vaccine 2015 33 3360 3366 10.1016/j.vaccine.2015.05.008 26027906

상세보기
41. Amanna I.J. Slifka M.K. Contributions of humoral and cellular immunity to vaccine-induced protection in humans Virology 2011 411 206 215 10.1016/j.virol.2010.12.016 21216425

상세보기
42. Sokolovska A. Hem S.L. HogenEsch H. Activation of dendritic cells and induction of cd4(+) t cell differentiation by aluminum-containing adjuvants Vaccine 2007 25 4575 4585 10.1016/j.vaccine.2007.03.045 17485153

상세보기
43. Didierlaurent A.M. Collignon C. Bourguignon P. Wouters S. Fierens K. Fochesato M. Dendouga N. Langlet C. Malissen B. Lambrecht B.N. Enhancement of adaptive immunity by the human vaccine adjuvant as01 depends on activated dendritic cells J. Immunol. 2014 193 1920 1930 10.4049/jimmunol.1400948 25024381

상세보기
44. Didierlaurent A.M. Morel S. Lockman L. Giannini S.L. Bisteau M. Carlsen H. Kielland A. Vosters O. Vanderheyde N. Schiavetti F. As04, an aluminum salt- and tlr4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity J. Immunol. 2009 183 6186 6197 10.4049/jimmunol.0901474 19864596

상세보기

LOADING...

활용도 분석정보

상세보기

다운로드

내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증